MDG1:FRA
MediGene AG
0,017 €
arrow_upward
+3,61%(+0,00060) 1D
30. jun., 21.00.00 GMT+1 · EUR
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
Nyhedshistorier
Fra webkilder og nyhedspartnere
Traders Union
·
for 15 timer siden
Anthony Pompliano: Kun 8 S&P 500-selskaber vurderes at have attraktivt afkastpotentiale fremover
Yahoo Finance
·
for 21 timer siden
Tech stocks are now cheaper than the S&P 500 for the first time since 2017 — here's what history says comes next: Chart of the Day
Bloomberg
·
for 21 timer siden
Wall Street Strategists Call Stock Rout a Fresh Reason to Buy
AP News
·
for 1 dag siden
Carney welcomes Democrats’ push to end Trump’s tariffs on Canada after midterm victory
Profil
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia